Tear-Based Diagnostic Test for Red Eye Conditions Enters Clinical Study
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.
A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.
Exagen added new biomarkers to its AVISE CTD platform, enhancing diagnostic accuracy for SLE and rheumatoid arthritis (RA).
Thermo Fisher’s Phadia Laboratory Systems enhance the precision and speed of diagnosing autoimmune diseases, such as rheumatoid arthritis.
Read MoreACCU Reference Medical Lab launched molecular PCR panels for better diagnosis of tick-borne diseases to provide for better patient outcomes.
Read MoreAliveDx received IVDR CE mark for its microarray immunoassay to detect a specific IgE directed to a protein allergen in human serum.
Read MoreA new study reveals that 80% of asthma patients suffer from allergic rhinitis, with significant skin test reactivity to various allergens.
Read MoreNew research links specific genetic mutations to subsets of lupus patients, enabling personalized treatments that target toll-like receptors.
Read MoreAMPEL BioSolutions’ predictive AI-driven blood test for Lupus forecasts patient flares and drug targets from gene expression.
Read MoreThe personal journey of co-author and physician Dana Mitchell details the challenges of accurate diagnosis of autoimmune encephalitis.
Read MoreThe emerging Powassan virus in ticks can cause life-threatening neuroinvasive disease, including encephalitis and meningitis.Â
Read MoreThe FDA has cleared Xpert Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of GBS.
Read MoreNew studies have added at least six novel urine biomarkers of active renal lupus validated across two ethnically diverse patient cohorts
Read MoreSavara Inc. recently a new serum-based blood test that can be used by physicians to obtain a definitive diagnosis of aPAP.
Read MoreThermo Fisher Scientific signed a distribution agreement with Aesku to market, sell, and support their portfolio of IFA products in the U.S.
Read MoreQuest and Scipher Medicine will collaborate to expand access to diagnostic services advancing precision medicine for rheumatoid arthritis.
Read MoreAqtual demonstrated its platform can identify synovial gene expression signatures in patients with rheumatoid arthritis using a blood test.Â
Read MoreMayo Clinic’s new collaboration will bring Progentec’s suite of biomarker blood tests for the management of autoimmune diseases to market.Â
Read More